Parthenon posts 90% IRR on med tech deal
Parthenon Capital has sold its controlling stake in Spheris, a US medical transcription business, to private equity groups Warburg Pincus and Soros Private Equity for an undisclosed amount.
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .Issues with signing in? Click here
Don't have an account? Register now
Parthenon Capital has sold its controlling stake in Spheris, a US medical transcription business, to private equity groups Warburg Pincus and Soros Private Equity for an undisclosed amount.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group.Copyright PEI Media
Not for publication, email or dissemination